DNMT3A and congenital bilateral aplasia of vas deferens from CFTR mutation: Before our study, another work reported that CHIP mutations in TET2 and DNMT3A occur frequently in patients with CAVD and that CHIP presence at the valve replacement time determines a poor prognosis after successful TAVI11.